Calsina Juscafresa L, Llort Pont C, Clará Velasco A
Vascular Surgery Department, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain -
Int Angiol. 2014 Oct;33(5):441-5.
Evaluate efficacy and safety of diagnostic and therapeutic endovascular interventions performed through transbrachial approach. Transbrachial artery catheterization has long been considered a secondary access site due to its related complication rate (7-11%). Low-profile and long-delivery endovascular systems, however, are reviving the interest in this approach.
We retrospectively analysed all endovascular interventions attempted through a brachial artery access from 2003 to 2010. Two hundredth thirty seven consecutive patients (mean age 68.5 years, 89.5% male) underwent 168 transbrachial diagnostic (70.9%) and 69 therapeutic procedures (29.1%), characterised by micropuncture access (100%), 4-to-7 Fr sheath delivery systems and final digital compression (100%). CUSUM curves were created to evaluate learning effects and quality of care.
All but one procedure were completed according to their scheduled intention. The overall complication rate was 5.5% (5 pseudoaneurysms (2.1%), 4 transient ischemic attack (1.7%), 3 brachial artery thromboses (1.3%) and 1 cardiac tamponade (0.4%). Surgical intervention was required in four of these patients (30.8%). No significant differences were observed according to age or sex. CUSUM curves created at a 2% theoretical risk showed two statistically significant upward inflections: one early in the series associated with diagnostic procedures (P=0.043) and another at the end of the study related to therapeutic interventions (P=0.018).
Transbrachial catheterization is an effective and relatively safe access site for endovascular procedures. Its complication rate, although lower than before, still deserve it as a secondary access site. CUSUM curves let identify learning effects in diagnostic and interventional procedures.
评估经肱动脉途径进行诊断性和治疗性血管内介入操作的有效性和安全性。由于经肱动脉插管相关并发症发生率(7 - 11%),长期以来它一直被视为次要的入路部位。然而,低外形和长输送血管内系统正在重新唤起人们对这种方法的兴趣。
我们回顾性分析了2003年至2010年期间所有经肱动脉入路尝试的血管内介入操作。237例连续患者(平均年龄68.5岁,89.5%为男性)接受了168例经肱动脉诊断性操作(70.9%)和69例治疗性操作(29.1%),其特点为微穿刺入路(100%)、4至7 Fr鞘管输送系统以及最终指压止血(100%)。绘制累积和(CUSUM)曲线以评估学习效应和医疗质量。
除1例操作外,所有操作均按预定计划完成。总体并发症发生率为5.5%(5例假性动脉瘤(2.1%)、4例短暂性脑缺血发作(1.7%)、3例肱动脉血栓形成(1.3%)和1例心脏压塞(0.4%))。其中4例患者(30.8%)需要手术干预。未观察到年龄或性别方面的显著差异。以2%理论风险绘制的CUSUM曲线显示出两个具有统计学意义的上升拐点:一个在系列操作早期与诊断性操作相关(P = 0.043),另一个在研究末期与治疗性干预相关(P = 0.018)。
经肱动脉插管是血管内操作的一种有效且相对安全的入路部位。其并发症发生率虽低于以往,但仍应将其视为次要入路部位。CUSUM曲线有助于识别诊断性和介入性操作中的学习效应。